IOPtima

2 stories about IOPtima
BioLight ביולייט איי אופטימה IOPtima

Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company

27.09.18|Lilach Baumer
The company paid $7 million in 2017 for 19% of IOPtima, a developer of minimally invasive devices for eye surgery
BioLight ביולייט איי אופטימה IOPtima

Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima

21.11.17|Lilach Baumer
The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange